Dr. Jacqueline Tsai, MD

Dr. Tsai practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Tsai's NPI, 1205103942, was assigned on November 23, 2011. Dr. Tsai graduated from Rutgers New Jersey Medical School in 2008. Dr. Tsai's California license number on file is A137638.

Dr. Tsai's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Tsai's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Tsai to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Tsai's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Tsai is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Tsai's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists breast reconstruction, cancerous skin growth removal and mastectomy among the conditions Dr. Tsai treats.

CMS data shows 219 Medicare services from Dr. Tsai across 7 procedure codes in 2024, for 131 Medicare patients. Medicare paid $32,992 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Tsai in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 74% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 51, with 98% women.

In 2024, Dr. Tsai wrote 21 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. They cover 2 drugs, with $402 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tsai for performance year 2024, reported as part of a group. Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tsai as offering telehealth. CMS counts 54 procedures of mastectomy by Dr. Tsai, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Tsai, published from 2016 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Mastectomy and Nipples. Dr. Tsai has published most often in Ann Surg Oncol. Dr. Tsai's most frequent co-authors are Irene Leonor Wapnir, MD, Tammy E. Ju, MD and Arash Momeni, MD.

CMS Open Payments shows 2 general payments to Dr. Tsai from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $147.

Dmand AI lists 1 award for Dr. Tsai.

Dr. Tsai graduated from Rutgers New Jersey Medical School in 2008. Dr. Tsai is a member of ACS.

Dr. Tsai is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.